Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodows, R. G.
Right arrow Articles by Kubasik, N. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodows, R. G.
Right arrow Articles by Kubasik, N. P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 9, Issue 2 189-193, Copyright © 1986 by American Diabetes Association


ARTICLES

Evaluation of a new radioimmunoassay for urinary albumin

RG Brodows, D Nichols, G Shaker and NP Kubasik

We have evaluated a new commercially available radioimmunoassay kit for albumin determination in urine. The assay is precise; within-run precision (CV) in the clinically significant ranges is 1.8-3.5%, between-run, 1.2-8.5%. The minimum detection limit was 0.6 micrograms/ml. Analytic recovery of different concentrations of albumin added to urine ranged from 98% to 103%. Samples, stored in plastic containers, were stable at room temperature for periods up to 7 days. Mean albumin excretion rates, measured in 20 normal volunteers for 3-h and 24-h periods during the same day were similar (7.1 +/- 4.6 [SD] versus 6.5 +/- 5.0 micrograms/min). In 8 normal subjects, 3-h excretion rates measured daily for 5 days showed no significant variability. In eight insulin-dependent diabetic subjects, albumin excretion measured in short periods of urine collection (3 h) were also in close agreement with 24-h collections (24.7 +/- 28.9 versus 17.6 +/- 18 micrograms/min). From these results it appears that this commercially available kit is suitable for conveniently monitoring microalbuminuria in large numbers of patients in research studies as well as for office practice. Such widespread use should make it possible to better determine the clinical usefulness of this test in the management of diabetic patients.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
T. Narita, M. Hosoba, M. Kakei, and S. Ito
Increased Urinary Excretions of Immunoglobulin G, Ceruloplasmin, and Transferrin Predict Development of Microalbuminuria in Patients With Type 2 Diabetes
Diabetes Care, January 1, 2006; 29(1): 142 - 144.
[Full Text] [PDF]


Home page
Diabetes CareHome page
T. Narita, H. Sasaki, M. Hosoba, T. Miura, N. Yoshioka, T. Morii, T. Shimotomai, J. Koshimura, H. Fujita, M. Kakei, et al.
Parallel Increase in Urinary Excretion Rates of Immunoglobulin G, Ceruloplasmin, Transferrin, and Orosomucoid in Normoalbuminuric Type 2 Diabetic Patients
Diabetes Care, May 1, 2004; 27(5): 1176 - 1181.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G Berton, R Cordiano, R Palmieri, F Cucchini, R de Toni, and P Palatini
Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality
Eur. Heart J., August 2, 2001; 22(16): 1466 - 1475.
[Abstract] [PDF]


Home page
HypertensionHome page
A. S. Reddi, V. R. Nimmagadda, A. Lefkowitz, H.-R. Kuo, and J. S. Bollineni
Effect of Antihypertensive Therapy on Renal Injury in Type 2 Diabetic Rats With Hypertension
Hypertension, August 1, 2000; 36(2): 233 - 238.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Berton, T. Citro, R. Palmieri, S. Petucco, S. Renzo De Toni, and P. Palatini
Albumin Excretion Rate Increases During Acute Myocardial Infarction and Strongly Predicts Early Mortality
Circulation, November 18, 1997; 96(10): 3338 - 3345.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. N. Jyothirmayi, I. Alluru, and A. S. Reddi
Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats
Hypertension, May 1, 1996; 27(5): 1108 - 1114.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1986 by the American Diabetes Association.